Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.19.3.a.u2
CONSOLIDATED BALANCE SHEETS - USD ($)
Nov. 30, 2019
Aug. 31, 2019
Current    
Cash and cash equivalents $ 1,333,321 $ 1,285,147
Marketable securities (Note 19) 22,640 64,214
Accounts receivable (Note 7) 325,901 273,145
Inventory (Note 8) 133,556 127,396
Prepaid expenses and deposit (Note 18) 96,067 68,927
Total Current Assets 1,911,485 1,818,829
Patent (Note 9) 269,416 265,127
Property & Equipment (Note 10) 565,172 591,263
Total Noncurrent Assets 834,588 856,390
TOTAL ASSETS 2,746,073 2,675,219
Current    
Accounts payable and accrued liabilities (Note 11) 93,029 136,411
Due to a related party (Note 15) 37,200 48,096
Total Current Liabilities 130,229 184,507
TOTAL LIABILITIES 130,229 184,507
STOCKHOLDERS' EQUITY    
220,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 80,610,879 common shares at November 30, 2019 and 78,787,134 common shares at August 31, 2019 80,611 78,787
Additional paid-in capital (Note 12, 13) 27,220,524 26,172,453
Deficit (24,775,515) (23,868,202)
Equity attributable to shareholders of the Company 2,525,620 2,383,038
Non-Controlling Interest 90,224 107,674
Total Stockholders\' Equity 2,615,844 2,490,712
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,746,073 $ 2,675,219